Andrew J King (Andrew King)

Publication Activity (10 Years)

Years Active: 2019-2019
Publications (10 Years): 2

Top Topics

Monoclonal Antibody

Replacement Therapy

Top Venues

Clinical transplantation

Science translational medicine

Ardelyx Inc

Michigan State University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ardelyx Inc Sep 01 2015

United States

Sr Director, Discovery and Translational Biology :: Research

Education History

Michigan State University

United States

PHD :: Department of Pharmacology and Toxicology

Murdoch University

Australia

PHD

Murdoch University

Australia

BSC

Publications

Efrat T Harel, Jun Shoji, Vivek Abraham, Loan Miller, Zoltan G Laszik, Tine Thurison, Andrew J King, Adam B Olshen, Joey Leung, Gyula Szabo, Byron C Hann, Gunilla Høyer-Hansen, Charles S Craik, Flavio G Vincenti
Identifying a potential biomarker for primary focal segmental glomerulosclerosis and its association with recurrence after transplantation. Clinical transplantation 33 (3) (2019)
Andrew J King, Matthew Siegel, Ying He, Baoming Nie, Ji Wang, Samantha Koo-McCoy, Natali A Minassian, Qumber Jafri, Deng Pan, Jill Kohler, Padmapriya Kumaraswamy, Kenji Kozuka, Jason G Lewis, Dean Dragoli, David P Rosenbaum, Debbie O'Neill, Allein Plain, Peter J Greasley, Ann-Cathrine Jönsson-Rylander, Daniel Karlsson, Margareta Behrendt, Maria Strömstedt, Tina Ryden-Bergsten, Thomas Knöpfel, Eva M Pastor Arroyo, Nati Hernando, Joanne Marks, Mark Donowitz, Carsten Alexander Wagner, Robert Todd Alexander, Jeremy S Caldwell
Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability. Science translational medicine 10 (456) (2019)